OmniBRx Biotechnologies strives to revolutionize the quality, scalability and predictability of biologics manufacturing including vaccine, M’Abs and therapeutic mammalian protein production. We are a biotech company specifically focused on upstream bioprocessing solutions. We have entered in the bioprocessing market with the most advanced, efficient and scalable CellBRx™ range of bioreactors for adherent cell culture bioprocessing. We are ready to serve and be a trusted partner with global biopharmaceuticals to develop and manufacture game-changing bioprocessing solutions. We manufacture automated single-use perfusion bioreactor systems and provide custom services for GMP production from pre-clinical to commercial in mg to kg quantities.